ProShares UltraShort NASDAQ Biotechnology
0
Funds holding %
of 6,759 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 6 [Q1] → 6 (+0) [Q2]
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
12.97% less ownership
Funds ownership: 24.59% [Q1] → 11.61% (-12.97%) [Q2]
55% less capital invested
Capital invested by funds: $865K [Q1] → $387K (-$478K) [Q2]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Research analyst outlook
We haven’t received any recent analyst ratings for BIS.
Financial journalist opinion
We haven’t received any recent news articles for BIS.
Charts implemented using Lightweight Charts™